Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder.

Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder.

Item
http://www.wikidata.org/entity/Q33301235
Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanismsPrevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatmentA translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacyAntipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behaviorValidation of a claims-based antipsychotic polypharmacy measurePrevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.Drug-drug conditioning between citalopram and haloperidol or olanzapine in a conditioned avoidance response model: implications for polypharmacy in schizophreniaAntipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practiceRacial and ethnic disparities in the treatment of a Medicaid population with schizophrenia.Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysisAntipsychotic combinations for schizophrenia.Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.An investigation of the behavioral mechanisms of antipsychotic action using a drug-drug conditioning paradigmReducing antipsychotic polypharmacy among psychogeriatric and adult patients with chronic schizophrenia.Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial.
P2860

Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder.

Item
http://www.wikidata.org/entity/Q33301235
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Incidence and costs of polypha ...... a or schizoaffective disorder.
@ast
Incidence and costs of polypha ...... a or schizoaffective disorder.
@en
Incidence and costs of polypha ...... a or schizoaffective disorder.
@nl
type
label
Incidence and costs of polypha ...... a or schizoaffective disorder.
@ast
Incidence and costs of polypha ...... a or schizoaffective disorder.
@en
Incidence and costs of polypha ...... a or schizoaffective disorder.
@nl
prefLabel
Incidence and costs of polypha ...... a or schizoaffective disorder.
@ast
Incidence and costs of polypha ...... a or schizoaffective disorder.
@en
Incidence and costs of polypha ...... a or schizoaffective disorder.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Incidence and costs of polypha ...... a or schizoaffective disorder.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921